Researchers present NorthPole – a brain-inspired chip architecture that blends computation with memory to process data efficiently at low-energy costs. Since its inception, computing has been ...

SEATTLE, Jan. 6, 2026 /PRNewswire/ -- Variant Bio, a genomics-driven AI drug discovery company, today announced the launch of Inference, the world's first agentic genomic drug discovery platform.

The AI boom shows no signs of slowing, but while training gets most of the headlines, it’s inferencing where the real business impact happens. Every time a chatbot answers, a fraud alert triggers or a ...